| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | receptor localization to synapse | 3.80e-06 | 101 | 85 | 6 | GO:0097120 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 8.05e-06 | 115 | 85 | 6 | GO:0035418 | |
| GeneOntologyBiologicalProcess | regulation of receptor localization to synapse | 1.98e-05 | 39 | 85 | 4 | GO:1902683 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical NF-kappaB signal transduction | 2.83e-05 | 213 | 85 | 7 | GO:0043123 | |
| GeneOntologyBiologicalProcess | regulation of canonical NF-kappaB signal transduction | 3.17e-05 | 298 | 85 | 8 | GO:0043122 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 3.38e-05 | 148 | 85 | 6 | GO:1902414 | |
| GeneOntologyBiologicalProcess | positive regulation of NF-kappaB transcription factor activity | 3.79e-05 | 151 | 85 | 6 | GO:0051092 | |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | 6.51e-05 | 330 | 85 | 8 | GO:0007249 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 7.09e-05 | 169 | 85 | 6 | GO:0046718 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ARFGEF3 RELN RAP1A DENND4A RAP1B KALRN SH2D3C BAIAP2 DNMBP GARRE1 | 7.26e-05 | 538 | 85 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | symbiont entry into host | 8.87e-05 | 176 | 85 | 6 | GO:0044409 | |
| GeneOntologyBiologicalProcess | mitochondrial tRNA 3'-end processing | 1.00e-04 | 4 | 85 | 2 | GO:1990180 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | 1.02e-04 | 261 | 85 | 7 | GO:0051091 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1.45e-04 | 25 | 85 | 3 | GO:0098696 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 1.51e-04 | 278 | 85 | 7 | GO:0031503 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic vesicle exocytosis | 2.49e-04 | 6 | 85 | 2 | GO:2000301 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 2.50e-04 | 302 | 85 | 7 | GO:0022604 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell apoptotic process | 3.07e-04 | 32 | 85 | 3 | GO:0070233 | |
| GeneOntologyBiologicalProcess | mitochondrial RNA 3'-end processing | 3.48e-04 | 7 | 85 | 2 | GO:0000965 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 3.61e-04 | 228 | 85 | 6 | GO:0051701 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine morphogenesis | 3.69e-04 | 34 | 85 | 3 | GO:0061003 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 3.91e-04 | 150 | 85 | 5 | GO:0000018 | |
| GeneOntologyBiologicalProcess | tRNA 3'-end processing | 4.62e-04 | 8 | 85 | 2 | GO:0042780 | |
| GeneOntologyBiologicalProcess | regulation of cell shape | 5.10e-04 | 159 | 85 | 5 | GO:0008360 | |
| GeneOntologyBiologicalProcess | viral life cycle | 5.10e-04 | 340 | 85 | 7 | GO:0019058 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 5.13e-04 | 38 | 85 | 3 | GO:1902473 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.04e-04 | 113 | 86 | 5 | GO:0043073 | |
| GeneOntologyCellularComponent | female germ cell nucleus | 2.78e-04 | 31 | 86 | 3 | GO:0001674 | |
| Domain | RDM | 9.04e-07 | 5 | 85 | 3 | PF11002 | |
| Domain | RDM_domain_RFPL | 9.04e-07 | 5 | 85 | 3 | IPR022723 | |
| Domain | NEDD4/Bsd2 | 2.05e-05 | 2 | 85 | 2 | IPR019325 | |
| Domain | DUF2370 | 2.05e-05 | 2 | 85 | 2 | PF10176 | |
| Domain | PRY | 9.19e-04 | 42 | 85 | 3 | PF13765 | |
| Domain | PRY | 1.36e-03 | 48 | 85 | 3 | SM00589 | |
| Domain | PRY | 1.36e-03 | 48 | 85 | 3 | IPR006574 | |
| Domain | A/G_cyclase_CS | 2.66e-03 | 17 | 85 | 2 | IPR018297 | |
| Domain | Nucleotide_cyclase | 2.99e-03 | 18 | 85 | 2 | IPR029787 | |
| Domain | - | 2.99e-03 | 18 | 85 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 3.33e-03 | 19 | 85 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 3.33e-03 | 19 | 85 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 3.33e-03 | 19 | 85 | 2 | PS50125 | |
| Domain | A/G_cyclase | 3.33e-03 | 19 | 85 | 2 | IPR001054 | |
| Domain | CYCc | 3.33e-03 | 19 | 85 | 2 | SM00044 | |
| Domain | Butyrophylin | 4.00e-03 | 70 | 85 | 3 | IPR003879 | |
| Pubmed | Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. | 1.46e-08 | 3 | 86 | 3 | 18656177 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 10508838 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 11850190 | ||
| Pubmed | RFPL4 interacts with oocyte proteins of the ubiquitin-proteasome degradation pathway. | 8.10e-07 | 8 | 86 | 3 | 12525704 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 13679863 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 25807985 | ||
| Pubmed | Rap1 Is Essential for B-Cell Locomotion, Germinal Center Formation and Normal B-1a Cell Population. | 6.04e-06 | 2 | 86 | 2 | 34140948 | |
| Pubmed | NKCC2A and NFAT5 regulate renal TNF production induced by hypertonic NaCl intake. | 6.04e-06 | 2 | 86 | 2 | 23269645 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 29222111 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 3141412 | ||
| Pubmed | Enhanced cortico-amygdala efficacy and suppressed fear in absence of Rap1. | 6.04e-06 | 2 | 86 | 2 | 18305243 | |
| Pubmed | Differential regulation of NFAT5 by NKCC2 isoforms in medullary thick ascending limb (mTAL) cells. | 6.04e-06 | 2 | 86 | 2 | 21228109 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32677671 | ||
| Pubmed | Mutation in RAP1 is a rare event in myelodysplastic syndromes. | 6.04e-06 | 2 | 86 | 2 | 16118622 | |
| Pubmed | Mutation analysis of RAP1 gene in papillary thyroid carcinomas. | 6.04e-06 | 2 | 86 | 2 | 18948674 | |
| Pubmed | Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts. | 6.04e-06 | 2 | 86 | 2 | 9330640 | |
| Pubmed | Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo. | 6.04e-06 | 2 | 86 | 2 | 24039860 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32651478 | ||
| Pubmed | Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition. | 6.04e-06 | 2 | 86 | 2 | 31403469 | |
| Pubmed | Promoting role of circ-Jarid2/miR-129-5p/Celf1 axis in cardiac hypertrophy. | 6.04e-06 | 2 | 86 | 2 | 32632266 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18805968 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 26804993 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32184389 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18191594 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 29443612 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 2108841 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18056377 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16926446 | ||
| Pubmed | Telomere-dependent and telomere-independent roles of RAP1 in regulating human stem cell homeostasis. | 6.04e-06 | 2 | 86 | 2 | 30796637 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18625726 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23946483 | ||
| Pubmed | 9.87e-06 | 197 | 86 | 6 | 36604605 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 24642466 | ||
| Pubmed | Rap1 signaling prevents L-type calcium channel-dependent neurotransmitter release. | 1.81e-05 | 3 | 86 | 2 | 23616533 | |
| Pubmed | Rap1 small GTPase is essential for maintaining pulmonary endothelial barrier function in mice. | 1.81e-05 | 3 | 86 | 2 | 38010922 | |
| Pubmed | Small GTPase Rap1 Is Essential for Mouse Development and Formation of Functional Vasculature. | 1.81e-05 | 3 | 86 | 2 | 26714318 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 32539601 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 18422604 | ||
| Pubmed | Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex. | 1.81e-05 | 3 | 86 | 2 | 21516100 | |
| Pubmed | Rap1 and its effector RIAM are required for lymphocyte trafficking. | 1.81e-05 | 3 | 86 | 2 | 26324702 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 25489104 | ||
| Pubmed | Dual functions of Rap1 are crucial for T-cell homeostasis and prevention of spontaneous colitis. | 1.81e-05 | 3 | 86 | 2 | 26634692 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22577140 | ||
| Pubmed | Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins. | 1.81e-05 | 3 | 86 | 2 | 19343052 | |
| Pubmed | Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B. | 1.81e-05 | 3 | 86 | 2 | 27760305 | |
| Pubmed | Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes. | 1.81e-05 | 3 | 86 | 2 | 20733035 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 2507536 | ||
| Pubmed | ARFGEF3 RAP1A TRMT10C HCN4 KALRN GUCY1B1 ANKS1B DAG1 UBR3 BAIAP2 ELFN2 CNOT2 | 2.36e-05 | 1139 | 86 | 12 | 36417873 | |
| Pubmed | Caspase-11 controls interleukin-1β release through degradation of TRPC1. | 3.61e-05 | 4 | 86 | 2 | 24630989 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 26844834 | ||
| Pubmed | Sema3e/Plexin D1 Modulates Immunological Synapse and Migration of Thymocytes by Rap1 Inhibition. | 3.61e-05 | 4 | 86 | 2 | 26921307 | |
| Pubmed | Functional redundancy between RAP1 isoforms in murine platelet production and function. | 3.61e-05 | 4 | 86 | 2 | 30131434 | |
| Pubmed | Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer. | 3.61e-05 | 4 | 86 | 2 | 29882482 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 26363003 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 27088444 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 33974562 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 20554528 | ||
| Pubmed | Rap1 activation plays a regulatory role in pancreatic amylase secretion. | 3.61e-05 | 4 | 86 | 2 | 18577515 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 26483383 | ||
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 4.78e-05 | 80 | 86 | 4 | 19389623 | |
| Pubmed | Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃. | 6.01e-05 | 5 | 86 | 2 | 21636859 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 15611229 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 18776082 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 35418690 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 37545505 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 19015241 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 21480213 | ||
| Pubmed | ELAVL2-directed RNA regulatory network drives the formation of quiescent primordial follicles. | 6.24e-05 | 31 | 86 | 3 | 31657143 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 7.26e-05 | 410 | 86 | 7 | 26949251 | |
| Pubmed | SLC6A2 PMS2 RAP1B TRNT1 CELF1 ESRP1 DAG1 ZFYVE1 NFAT5 CNOT2 ATP6V0A2 | 7.42e-05 | 1084 | 86 | 11 | 11544199 | |
| Pubmed | RELN PMS2 KALRN GUCY1B1 UBQLN4 ETS2 ANKS1B ZBTB5 USP54 BAIAP2 TUBGCP5 CNOT2 | 7.54e-05 | 1285 | 86 | 12 | 35914814 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 7.71e-05 | 724 | 86 | 9 | 36232890 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 8.47e-05 | 569 | 86 | 8 | 30639242 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 11245989 | ||
| Pubmed | Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia. | 9.01e-05 | 6 | 86 | 2 | 36001955 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 29320740 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 23230271 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 28137909 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 30354217 | ||
| Pubmed | IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function. | 9.01e-05 | 6 | 86 | 2 | 37598341 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 11748237 | ||
| Pubmed | Direct Binding of Rap1 to Talin1 and to MRL Proteins Promotes Integrin Activation in CD4+ T Cells. | 9.01e-05 | 6 | 86 | 2 | 35197328 | |
| Pubmed | 1.07e-04 | 37 | 86 | 3 | 16707424 | ||
| Pubmed | NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. | 1.07e-04 | 37 | 86 | 3 | 15326356 | |
| Pubmed | 1.11e-04 | 304 | 86 | 6 | 32235678 | ||
| Pubmed | Distinct integrin activation pathways for effector and regulatory T cell trafficking and function. | 1.26e-04 | 7 | 86 | 2 | 33104169 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 25721469 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 28039900 | ||
| Pubmed | RASA3 is a critical inhibitor of RAP1-dependent platelet activation. | 1.26e-04 | 7 | 86 | 2 | 25705885 | |
| Pubmed | Rap1 regulates lumen continuity via Afadin in renal epithelia. | 1.26e-04 | 7 | 86 | 2 | 37276970 | |
| Pubmed | Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. | 1.26e-04 | 7 | 86 | 2 | 21840392 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.30e-04 | 313 | 86 | 6 | 38270169 | |
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 22456507 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 24036464 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 20534535 | ||
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 30893602 | ||
| Pubmed | 2.15e-04 | 9 | 86 | 2 | 24586238 | ||
| Pubmed | 2.15e-04 | 9 | 86 | 2 | 2293612 | ||
| Pubmed | 2.15e-04 | 9 | 86 | 2 | 37267105 | ||
| Pubmed | Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. | 2.68e-04 | 10 | 86 | 2 | 25173105 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 1.53e-05 | 161 | 86 | 6 | M2121 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP | 4.77e-05 | 197 | 86 | 6 | M9917 | |
| Coexpression | GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.90e-05 | 198 | 86 | 6 | M9163 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN | 5.18e-05 | 200 | 86 | 6 | M7850 | |
| Coexpression | GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN | 5.18e-05 | 200 | 86 | 6 | M7240 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP | 5.18e-05 | 200 | 86 | 6 | M8657 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TREG_UP | 5.18e-05 | 200 | 86 | 6 | M5743 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 7.60e-06 | 120 | 83 | 6 | gudmap_kidney_adult_RenMedVasc_Tie2_k3_500 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 9.01e-08 | 191 | 86 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.01e-08 | 191 | 86 | 7 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-07 | 195 | 86 | 7 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-07 | 195 | 86 | 7 | 1e794839a251fbc6e6ce419b4c457ead35a04735 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-07 | 196 | 86 | 7 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-06 | 177 | 86 | 6 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-06 | 177 | 86 | 6 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-06 | 177 | 86 | 6 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-06 | 179 | 86 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 181 | 86 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 183 | 86 | 6 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-06 | 183 | 86 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-06 | 184 | 86 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-06 | 185 | 86 | 6 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-06 | 186 | 86 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 186 | 86 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.70e-06 | 187 | 86 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 189 | 86 | 6 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 189 | 86 | 6 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-06 | 190 | 86 | 6 | a51405f8466fc6d4087873137472619b2e84c1da | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.86e-06 | 190 | 86 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 190 | 86 | 6 | aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 190 | 86 | 6 | a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-06 | 190 | 86 | 6 | 64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 190 | 86 | 6 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-06 | 190 | 86 | 6 | 059beca1c92181b8ba4dcd6fc71ff7530d83d0de | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 191 | 86 | 6 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.10e-06 | 194 | 86 | 6 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-06 | 194 | 86 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.16e-06 | 195 | 86 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 195 | 86 | 6 | fa5fc6f605deb5cae96eec14ba4000b19f877ba6 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 2.16e-06 | 195 | 86 | 6 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.29e-06 | 197 | 86 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.29e-06 | 197 | 86 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-06 | 198 | 86 | 6 | fcf53d6ac2e442400fa0c07c6de72e00a9143ba2 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.97e-05 | 170 | 86 | 5 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 174 | 86 | 5 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-05 | 179 | 86 | 5 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 182 | 86 | 5 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 182 | 86 | 5 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-05 | 182 | 86 | 5 | 4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 182 | 86 | 5 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-05 | 183 | 86 | 5 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-05 | 183 | 86 | 5 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.89e-05 | 184 | 86 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-05 | 184 | 86 | 5 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.96e-05 | 185 | 86 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-05 | 185 | 86 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.04e-05 | 186 | 86 | 5 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-05 | 187 | 86 | 5 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-05 | 187 | 86 | 5 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-05 | 188 | 86 | 5 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 188 | 86 | 5 | b1049003ca79c340bb8c78da66bdc0956e1aebc2 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.20e-05 | 188 | 86 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-05 | 188 | 86 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 188 | 86 | 5 | 3dd571bd8e7358b4346dea71f6bf9602dabf583c | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-05 | 188 | 86 | 5 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 188 | 86 | 5 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 3.28e-05 | 189 | 86 | 5 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.28e-05 | 189 | 86 | 5 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 189 | 86 | 5 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.28e-05 | 189 | 86 | 5 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 190 | 86 | 5 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 3.36e-05 | 190 | 86 | 5 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 190 | 86 | 5 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 191 | 86 | 5 | f98fc372e579ce69409afbbe0f83c03c7ea62632 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 191 | 86 | 5 | 210589095a3f5d5117174caf6ec110b502f27030 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.45e-05 | 191 | 86 | 5 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | Control-Lymphoid-ILC_A|Control / Disease state, Lineage and Cell class | 3.45e-05 | 191 | 86 | 5 | 1ca73582dc3d28322b5ee841010067589d848acc | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.45e-05 | 191 | 86 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | 629007189034ee8451411428f1c6cc57daee2d91 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-05 | 192 | 86 | 5 | 4a46f7980ec145be5b4bf8b98265e3e0f2ea4c63 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.54e-05 | 192 | 86 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 3.54e-05 | 192 | 86 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.54e-05 | 192 | 86 | 5 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.54e-05 | 192 | 86 | 5 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 192 | 86 | 5 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.54e-05 | 192 | 86 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 3.62e-05 | 193 | 86 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 193 | 86 | 5 | 4a1b4a2faf741ffba5c84218af4df6a8b2a9f4de | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial-type_II_pneumocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 193 | 86 | 5 | 68adc680deb2f1a29d3cca19c13b9f6271dd4d60 | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 193 | 86 | 5 | 819e6ee2ffa3e31bf9a2d57c99d9e3eac7072765 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 193 | 86 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-05 | 193 | 86 | 5 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-05 | 193 | 86 | 5 | 3d4411b3c1cb160dec5db29f0c126d8827dfe185 | |
| ToppCell | HSPCs-Mk_prog.|HSPCs / Lineage and Cell class | 3.71e-05 | 194 | 86 | 5 | 5c05d508f5c29e6efe87506bf59e3b0fe5922f65 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.71e-05 | 194 | 86 | 5 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-05 | 194 | 86 | 5 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.71e-05 | 194 | 86 | 5 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 3.81e-05 | 195 | 86 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.90e-05 | 196 | 86 | 5 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 196 | 86 | 5 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 197 | 86 | 5 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 197 | 86 | 5 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.09e-05 | 198 | 86 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| Disease | Kabuki make-up syndrome | 4.45e-05 | 4 | 81 | 2 | C0796004 | |
| Disease | Gilles de la Tourette syndrome (is_implicated_in) | 1.11e-04 | 6 | 81 | 2 | DOID:11119 (is_implicated_in) | |
| Disease | glycylvaline measurement | 2.06e-04 | 8 | 81 | 2 | EFO_0021129 | |
| Disease | pulse pressure measurement | FMNL3 ZFHX4 CELF1 PLXNC1 UBR3 ZNF385B NME7 NFAT5 NNT GARRE1 HYDIN ITIH1 | 4.02e-04 | 1392 | 81 | 12 | EFO_0005763 |
| Disease | transferrin receptor protein 1 measurement | 6.63e-04 | 14 | 81 | 2 | EFO_0802142 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 7.64e-04 | 15 | 81 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | hydrocephalus (implicated_via_orthology) | 1.23e-03 | 19 | 81 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | body fat percentage | 2.26e-03 | 488 | 81 | 6 | EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNFRAVFMAVVMGQG | 506 | Q7Z695 | |
| LMGIVSNALMGIFNF | 896 | Q8WWZ4 | |
| RMAGQMLLQTFFNID | 66 | P49662 | |
| HSFNNFQMKIGLNMG | 1076 | O43306 | |
| DLLQMFMPFGNVVSA | 416 | Q92879 | |
| NIDFEGLFGNMQMVI | 821 | Q6XZF7 | |
| EEMNFVLMGGTLNRN | 526 | Q6NXG1 | |
| NRNLSGGVLMGFMLN | 1031 | Q7Z401 | |
| GGVLMGFMLNRINQE | 1036 | Q7Z401 | |
| DAMGFLLMFDLTSQQ | 91 | O00194 | |
| AMRDLYMKNGQGFAL | 66 | P62834 | |
| AMRDLYMKNGQGFAL | 66 | P61224 | |
| LMANGFDNVQFMGSN | 831 | Q7Z6G8 | |
| MGMEGLLQNSTNFVL | 1 | Q6IF00 | |
| FRNFSFMNPGMERLI | 691 | Q04759 | |
| GMFFAAMLQINSSLE | 196 | Q8IZ02 | |
| FNFLEVMSMENNGRA | 441 | P19827 | |
| GFMGINGDLNTLMEN | 571 | Q96EF0 | |
| LGGFNTNNMNMSRAS | 276 | Q5VYY2 | |
| VNNRLFDMSAFMAGP | 231 | Q14118 | |
| VLQSMNAFFQGLMLL | 1736 | Q5VYK3 | |
| RFGFAMAAMGDLSQD | 576 | P38570 | |
| ISGGQNITMMGRNFD | 766 | O60486 | |
| MLRVFLFNAMGISPN | 81 | Q8NH64 | |
| RFGMNGQMLCNLGKE | 131 | P15036 | |
| CNDMMNLGRLQGFEG | 2101 | O60229 | |
| QAMRNFFLMEGGDTM | 721 | Q96RT8 | |
| LNAGEILQMFGKMFF | 61 | Q02153 | |
| MQMNHALFSLNGRTG | 1021 | P16885 | |
| MGMEGLLQNSTNFVL | 1 | Q8NGX2 | |
| FTFLHLGSGDNMQVM | 291 | Q02509 | |
| FQQGNEMMSLQSGNF | 1046 | O94916 | |
| AGFMQRQFGAMLQPG | 211 | Q9Y3Q4 | |
| NNLFFNEDGLRMLMT | 2201 | P78509 | |
| RVGNDGIFMLAFFMA | 226 | Q9NV92 | |
| RIGNDGIFMLTFFMA | 111 | Q9BT67 | |
| GAVQMGLVNMFKGFQ | 11 | Q4G0P3 | |
| SGRFTMNMLVDIFLG | 1106 | P54132 | |
| RMAGMAFLGNFQDNL | 726 | Q8IVF7 | |
| GFDGNSSLSFQMLMN | 716 | Q5TH69 | |
| MQEVIDFLSGFNMGQ | 646 | O15063 | |
| QGVAAAKQMGLFMEF | 16 | Q5T0F9 | |
| LMMFFRHSNLGQGTN | 176 | Q68CZ6 | |
| EFRLMMTFSGLNRGF | 86 | Q8IYX4 | |
| AGMVAGMENNDRFSR | 386 | Q12912 | |
| RRSMVSPNFGFMGQL | 296 | Q16690 | |
| GFLNGRACVMMQGRF | 71 | P00491 | |
| IRDAGFEISAMQMFN | 261 | Q9Y5B8 | |
| ACFFRLINEMGGMQQ | 656 | Q92833 | |
| SMGMEDAFNKGRANF | 326 | P05120 | |
| IAGGFLVTQRMLDMF | 571 | Q13423 | |
| FSNDIQQMMGFRPGL | 501 | P23975 | |
| GIFLDMGMQNVSFFD | 246 | O75677 | |
| EMFQSAGIRMINNRG | 91 | Q96Q11 | |
| ALMGMFNSIFDGRVV | 151 | Q9UM00 | |
| AIIQMGLGFMQFGFV | 181 | Q7LBE3 | |
| MDGSFSFKLLNQLGM | 351 | Q6XZB0 | |
| AGQMLLVAFDGMFAQ | 2956 | Q96Q15 | |
| SFGLSVFNLMNAIMG | 46 | Q8IZM9 | |
| NNFQVMSMVSGFGPL | 481 | Q13621 | |
| MSQEMFVGIVGNQFK | 646 | Q8NEM2 | |
| MMDQARSAFSNLFGG | 1 | P02786 | |
| MEQFNPSLRNFIAMG | 21 | Q9UQB8 | |
| FTVNSMSGFGMNRNQ | 186 | Q9NZN8 | |
| LQISMGQMLQDFGKF | 526 | P48995 | |
| GQMLQDFGKFLGMFL | 531 | P48995 | |
| AMRDLYMKNGQGFAL | 66 | A6NIZ1 | |
| SGLDGNFNSIRMDMF | 3551 | Q86UP3 | |
| QSARMQRSFMLQQLG | 136 | O15062 | |
| RAVVCLQMGNNFAAM | 321 | Q86TZ1 | |
| MQSGGIFNMIFENPS | 141 | O14924 | |
| NRGDFFMTLRNQPMA | 586 | Q9H269 | |
| NGMPMDIVNTSGRFF | 276 | Q9Y639 | |
| MGFEFNIMVVGQSGL | 46 | Q8IYM1 | |
| VGIFLDMGMQNVSFF | 306 | O75678 | |
| GIFLDMGMQNVSFFD | 246 | O75679 | |
| MNMANFLRGFEEKGI | 1 | Q569K4 | |
| TMFAEMEIIGQFNLG | 671 | P54278 | |
| AAQRLLDGMNFMAQS | 556 | Q9HBF4 | |
| SALTILMLNGAMFFN | 86 | E9PQX1 | |
| LMLNGAMFFNRLSLE | 91 | E9PQX1 | |
| GTGMAFGLQMFIQRK | 41 | Q96I45 | |
| MNFVSFFQGMNLNKR | 541 | Q6ZT12 | |
| MDFFNAQMRLGGLTQ | 166 | P26368 | |
| LAAELRGTMGNMFSF | 671 | Q8N5H7 | |
| LGLGSANFMELQQQM | 171 | Q9NRR5 | |
| AQAMQFGQPLVFDMA | 196 | Q7L0Y3 | |
| RLNQSQEIMRMFFNG | 436 | Q9Y487 | |
| FQRMQGVSMRDSTGF | 1136 | Q70EL1 | |
| GMLRGMSRLQFLFVQ | 121 | Q5R3F8 |